company background image
BIOG B logo

BioGaia OM:BIOG B Stock Report

Last Price

SEK 106.20

Market Cap

SEK 10.3b

7D

2.2%

1Y

-20.0%

Updated

13 May, 2025

Data

Company Financials +

BioGaia AB (publ)

OM:BIOG B Stock Report

Market Cap: SEK 10.3b

BIOG B Stock Overview

A healthcare company, provides probiotic products worldwide. More details

BIOG B fundamental analysis
Snowflake Score
Valuation2/6
Future Growth3/6
Past Performance2/6
Financial Health6/6
Dividends4/6

Rewards

Earnings are forecast to grow 19.89% per year

Risk Analysis

Dividend of 6.5% is not well covered by free cash flows


Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

BIOG B logo
BioGaia
AN
AnalystConsensusTarget
Consensus Narrative from 1 Analyst

Launch Of Gastrus PURE ACTION And Prodentis Lozenges Will Expand Global Market Presence

Key Takeaways Strategic market expansion and direct sales initiatives in key countries could enhance net margins and revenue growth by capturing more customer value. Investments in R&D for new clinical studies may result in innovative products, driving future revenue and sustaining high EBIT margins through differentiation.
View narrative
SEK 150.00
FV
29.2% undervalued intrinsic discount
9.69%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
6users have followed this narrative
13 days ago author updated this narrative
View BioGaia Community

BioGaia AB (publ) Competitors

Vitrolife

OM:VITR

SEK 21.4b

Bonesupport Holding

OM:BONEX

SEK 19.4b

Swedish Orphan Biovitrum

OM:SOBI

SEK 104.3b

Saniona

OM:SANION

SEK 1.1b

Price History & Performance

Summary of share price highs, lows and changes for BioGaia
Historical stock prices
Current Share PriceSEK 106.20
52 Week HighSEK 139.70
52 Week LowSEK 93.50
Beta0.65
1 Month Change7.98%
3 Month Change-17.55%
1 Year Change-19.97%
3 Year Change3.91%
5 Year Change9.71%
Change since IPO1,244.31%

Recent News & Updates

Recent updates

author-image

Launch Of Gastrus PURE ACTION And Direct Operations Will Strengthen Future Prospects

Feb 22 Direct market investments and internalizing operations in key regions enhance revenue potential by reducing reliance on distributors and capturing full retail margins.

BioGaia's (STO:BIOG B) Soft Earnings Don't Show The Whole Picture

Oct 29
BioGaia's (STO:BIOG B) Soft Earnings Don't Show The Whole Picture

BioGaia (STO:BIOG B) Has Announced That It Will Be Increasing Its Dividend To SEK6.90

Apr 25
BioGaia (STO:BIOG B) Has Announced That It Will Be Increasing Its Dividend To SEK6.90

BioGaia's (STO:BIOG B) Shareholders Will Receive A Bigger Dividend Than Last Year

Apr 09
BioGaia's (STO:BIOG B) Shareholders Will Receive A Bigger Dividend Than Last Year

BioGaia (STO:BIOG B) Has Announced That It Will Be Increasing Its Dividend To SEK6.90

Mar 26
BioGaia (STO:BIOG B) Has Announced That It Will Be Increasing Its Dividend To SEK6.90

BioGaia (STO:BIOG B) Will Pay A Larger Dividend Than Last Year At SEK6.90

Mar 09
BioGaia (STO:BIOG B) Will Pay A Larger Dividend Than Last Year At SEK6.90

BioGaia (STO:BIOG B) Has Announced That It Will Be Increasing Its Dividend To SEK6.90

Feb 24
BioGaia (STO:BIOG B) Has Announced That It Will Be Increasing Its Dividend To SEK6.90

BioGaia's (STO:BIOG B) Upcoming Dividend Will Be Larger Than Last Year's

Feb 10
BioGaia's (STO:BIOG B) Upcoming Dividend Will Be Larger Than Last Year's

Here's Why We Think BioGaia (STO:BIOG B) Might Deserve Your Attention Today

Nov 27
Here's Why We Think BioGaia (STO:BIOG B) Might Deserve Your Attention Today

Calculating The Intrinsic Value Of BioGaia AB (publ) (STO:BIOG B)

Sep 13
Calculating The Intrinsic Value Of BioGaia AB (publ) (STO:BIOG B)

Does BioGaia (STO:BIOG B) Deserve A Spot On Your Watchlist?

Jun 02
Does BioGaia (STO:BIOG B) Deserve A Spot On Your Watchlist?

A Look At The Intrinsic Value Of BioGaia AB (publ) (STO:BIOG B)

Apr 27
A Look At The Intrinsic Value Of BioGaia AB (publ) (STO:BIOG B)

Do BioGaia's (STO:BIOG B) Earnings Warrant Your Attention?

Jan 14
Do BioGaia's (STO:BIOG B) Earnings Warrant Your Attention?

Do BioGaia's (STO:BIOG B) Earnings Warrant Your Attention?

Aug 26
Do BioGaia's (STO:BIOG B) Earnings Warrant Your Attention?

Does This Valuation Of BioGaia AB (publ) (STO:BIOG B) Imply Investors Are Overpaying?

Jul 24
Does This Valuation Of BioGaia AB (publ) (STO:BIOG B) Imply Investors Are Overpaying?

Calculating The Intrinsic Value Of BioGaia AB (publ) (STO:BIOG B)

Apr 02
Calculating The Intrinsic Value Of BioGaia AB (publ) (STO:BIOG B)

BioGaia's (STO:BIOG B) Shareholders Will Receive A Bigger Dividend Than Last Year

Feb 21
BioGaia's (STO:BIOG B) Shareholders Will Receive A Bigger Dividend Than Last Year

Need To Know: Analysts Are Much More Bullish On BioGaia AB (publ) (STO:BIOG B) Revenues

Feb 09
Need To Know: Analysts Are Much More Bullish On BioGaia AB (publ) (STO:BIOG B) Revenues

BioGaia's (STO:BIOG B) Upcoming Dividend Will Be Larger Than Last Year's

Feb 07
BioGaia's (STO:BIOG B) Upcoming Dividend Will Be Larger Than Last Year's

Shareholder Returns

BIOG BSE BiotechsSE Market
7D2.2%-0.3%2.6%
1Y-20.0%-2.1%-2.2%

Return vs Industry: BIOG B underperformed the Swedish Biotechs industry which returned -2.1% over the past year.

Return vs Market: BIOG B underperformed the Swedish Market which returned -2.2% over the past year.

Price Volatility

Is BIOG B's price volatile compared to industry and market?
BIOG B volatility
BIOG B Average Weekly Movement4.9%
Biotechs Industry Average Movement9.6%
Market Average Movement6.9%
10% most volatile stocks in SE Market13.5%
10% least volatile stocks in SE Market4.2%

Stable Share Price: BIOG B has not had significant price volatility in the past 3 months compared to the Swedish market.

Volatility Over Time: BIOG B's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1990225Theresa Agnewwww.biogaia.com

BioGaia AB (publ), a healthcare company, provides probiotic products worldwide. The company operates through Pediatrics, Adult Health, and Other segments. The Pediatrics segment offers drops, oral rehydration solutions, and gut health tablets, as well as cultures that are used as an ingredient in infant formula and milk formula.

BioGaia AB (publ) Fundamentals Summary

How do BioGaia's earnings and revenue compare to its market cap?
BIOG B fundamental statistics
Market capSEK 10.34b
Earnings (TTM)SEK 309.74m
Revenue (TTM)SEK 1.42b

34.7x

P/E Ratio

7.6x

P/S Ratio

Is BIOG B overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
BIOG B income statement (TTM)
RevenueSEK 1.42b
Cost of RevenueSEK 385.91m
Gross ProfitSEK 1.03b
Other ExpensesSEK 723.54m
EarningsSEK 309.74m

Last Reported Earnings

Mar 31, 2025

Next Earnings Date

Jul 18, 2025

Earnings per share (EPS)3.06
Gross Margin72.81%
Net Profit Margin21.83%
Debt/Equity Ratio0%

How did BIOG B perform over the long term?

See historical performance and comparison

Dividends

6.5%

Current Dividend Yield

64%

Payout Ratio

Does BIOG B pay a reliable dividends?

See BIOG B dividend history and benchmarks
When do you need to buy BIOG B by to receive an upcoming dividend?
BioGaia dividend dates
Ex Dividend DateMay 08 2025
Dividend Pay DateMay 14 2025
Days until Ex dividend6 days
Days until Dividend pay date0 days

Does BIOG B pay a reliable dividends?

See BIOG B dividend history and benchmarks

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/13 17:42
End of Day Share Price 2025/05/13 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

BioGaia AB (publ) is covered by 4 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Christopher UhdeABG Sundal Collier Sponsored
Kristofer Liljeberg-SvenssonCarnegie Investment Bank AB
Mattias HäggblomDanske Bank